Menu Menu Menu
Nice Insight Research
Content Menu
Menu Menu Menu
To Top

Content Filter


1495 Articles available
Expanded Capacity

WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services

PR-M04-18-NI-75
Collaboration

Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics

PR-M04-18-NI-64
Oncology

Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Superior Survival Benefit Compared with Chemotherapy

PR-M04-18-NI-65
Innovation

RightBio Metrics Receives Innovative Technology Contract from Vizient, Inc. for RightSpotpH® Indicators

Preclinical Data

Syros Announces New Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer

PR-M04-18-NI-67
CAR T

City of Hope Certified to Provide First FDA-Approved CAR T Cell Therapy for Pediatric and Young Adult Patients

PR-M04-18-NI-68
Collaboration

Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford

PR-M04-18-NI-64
Oncology

Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Disease Recurrence or Death by More than 40 Percent

PR-M04-18-NI-63
Oncology

Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network

PR-M04-18-NI-62
Expanded Capacity

SeraCare Announces Expansion of Industry's Most Complete and Patient-Like ctDNA Reference Materials

PR-M04-18-NI-61
FDA

Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems

PR-M04-18-NI-60
Immunotherapy

Immunotherapy Prior to Surgery Shows Promise in Fight Against Lung Cancer

PAO-M04-18-NI-016
CAR T

Pfizer and Allogene Therapeutics Form Alliance, Further Developing CAR-T Therapy

PAO-M04-18-NI-015
Innovation

Robotic Microscope Used for Brain Surgery

PAO-M04-18-NI-014
Clinical Trials

Marken Announces Plans To Add Nursing Services To Home-Based Trials

PR-M04-18-NI-69
FDA

New Lung Cancer Treatment Awarded Priority Review by FDA

PAO-M04-18-NI-013
Strategic Collaboration

United Neuroscience Ltd. and Boston University Lee Goldstein Laboratory Enter Collaboration, Targeting Treatment and Prevention of Chronic Traumatic Encephalopathy (CTE)

PAO-M04-18-NI-012
Strategic Partnership

Charles River Laboratories to Expand Partnership with PathoQuest

PAO-M04-18-NI-011
Approval

Fresenius Kabi Announces New Approval and Immediate Availability of Daptomycin for Injection

PR-M04-18-NI-58
Liquid Biopsy

Sysmex Inostics Expands OncoBEAM™ Liquid Biopsy Testing in the U.S. to Assist Clinicians and Patients

PR-M04-18-NI-57
Preclinical Data

Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia

PR-M04-18-NI-56
Drug Delivery

Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting

PR-M04-18-NI-55
FDA Guidance

FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests

PR-M04-18-NI-54
Acquisition

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

PR-M04-18-NI-59
Animal Health

LEUKOCARE and Boehringer Ingelheim Enter into a Long-Term Agreement in the Field of Animal Health

PR-M04-18-NI-53
Collaboration

Evotec Forms Collaboration with Petra Pharma on Indigo Platform

PR-M04-18-NI-52
Clinical Trials

Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery

PR-M04-18-NI-51
Launch

Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn

PR-M04-18-NI-50
Drug Development

Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures

PR-M04-18-NI-49
Cloud

Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet

PR-M04-18-NI-48
Innovation

Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery

PR-M04-18-NI-47
FDA

Kadmon Receives FDA Guidance on Pivotal Clinical Trial Design for KD025 in Chronic Graft-Versus-Host Disease

PR-M04-18-NI-46
Next Generation

Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

PR-M04-18-NI-45
Immuno-Oncology

FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel Immuno-Oncology Therapies

PR-M04-18-NI-44
Oncology

New Breast Cancer Drug Accepted for Review by EMA

PAO-M04-18-NI-010
Clinical Trials

Eli Lilly Gets Good News for Cyramza

PAO-M04-18-NI-009
Acquisition

GSK to Take Over Full Ownership of Consumer Healthcare JV with Novartis

PAO-M04-18-NI-008
Strategic Collaboration

Compugen, MedImmune to Collaborate on Bi- and Multi-Specific Antibodies

PAO-M04-18-NI-007
Strategic Collaboration

Science Exchange and Ranomics Collaborate to Offer Online Access to their VariantFindTM Mutagenesis Platform

PR-M04-18-NI-43
FDA Approval

Rubraca® (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer

PR-M04-18-NI-41
Industry

Casdin Capital to Become Shareholder in BioLife Solutions

PR-M04-18-NI-42
Immuno-oncology

Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio

PR-M04-18-NI-40
Strategic Partnership

Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership

PR-M04-18-NI-39
Drug Discovery

"Transcriptional wiring" of cancer genes can be resolved using Lexogen's SLAMseq and QuantSeq technologies to facilitate drug discovery

PR-M04-18-NI-38
Acquisition

ImmunoPrecise Acquires ModiQuest Research BV

PR-M04-18-NI-37
Monoclonal antibody

Alopexx Pharmaceuticals' F598 Monoclonal Antibody Binds to poly-N-acetylglucosamine (PNAG) on Microbial Surfaces Offering Potential Protective Immunity Against Multiple Pathogens

PR-M04-18-NI-36
Pharma

Applied DNA Signs Definitive Agreements with Colorcon for Molecular Tagging in the Pharmaceutical and Nutraceutical Markets

PR-M04-18-NI-35
Acquisition

Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio

PR-M04-18-NI-34
Clinical Trials

First Patient Treated in Pivotal Phase 3 Trial to Evaluate OTL38 in the Detection of Ovarian Cancer

PR-M04-18-NI-33
Announcement

Charlotte Radiology and Welsh, Carson, Anderson & Stowe Announce the Formation of US Radiology Specialists, Appoint New CEO

PR-M04-18-NI-031
Immuno-Oncology

Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership

PR-M04-18-NI-030
Acquisition

UCB Strengthens Research Capabilities With Acquisition of Element Genomics, a Duke University Biotech Spin-off

PR-M04-18-NI-32
Diagnostics

Pharos Diagnostics Expands Diagnostic Testing Menu to include Routine Testing and Valley Fever (Cocci)

PR-M04-18-NI-025
Acquisition

Terns Pharmaceuticals Acquires Global, Exclusive Rights to Develop and Commercialize Three NASH Assets from Lilly

PR-M04-18-NI-026
Strategic Collaboration

IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets

PR-M04-18-NI-027
Research

Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Initiative

PR-M04-18-NI-028
Strategic Collaboration

Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes

PR-M04-18-NI-029
Collaboration

Kymera Therapeutics Announces Discovery Collaboration with GSK to Advance New Treatment Modality

PR-M04-18-NI-024
Acquisition

Inception Neuroscience Program Acquired by Roche

PR-M04-18-NI-023
CAR T

Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio

PR-M04-18-NI-022
CDMO

European Commission Approves Expanded Indication For Amgen's XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma

PR-M04-18-NI-021
Fast Track

U.S. FDA Grants Fast Track Designation to TARIS® for TAR-200 (GemRIS™) in Muscle Invasive Bladder Cancer

PR-M04-18-NI-020
Clinical Trials

SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial

PR-M04-18-NI-020
NDA

Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate

PR-M04-18-NI-019
Results

Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression

PR-M04-18-NI-018
Acquistion

HGS Acquires AxisPoint Health

PR-M04-18-NI-017
Expanded Capacity

AGC Biologics Increases Footprint in Bothell, WA

PR-M04-18-NI-016
Equipment

Successful Solid Dose Equipment Training

PA0-M04-18-CL-004
Diabetes

Sanofi’s Sotagliflozin Accepted for Review by EMA

PAO-M04-18-NI-006
Approval

Amgen Gets Expanded Approval for Blincyto®

PAO-M04-18-NI-005
Antibiotics

Macrolide Attracts Funding and Executive Talent

PAO-M04-18-NI-004
Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

PAO-M04-18-NI-003
Results

Positive Results for Pfizer Drug Tafamidis

PAO-M04-18-NI-001
Radio-Conjugates

Companies Join Forces to Develop Novel Radio-Conjugates

PAO-M04-18-NI-002
Clinical Trials

MediciNova Announces Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD will be Terminated Early based on Significant Positive Results from Interim Analysis

PR-M04-18-NI-014
Next Generation

First Patient Treated on Mevion's Next Generation Proton Therapy System

PR-M04-18-NI-013
Earnings

Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast

PR-M04-18-NI-012
Results

Sientra Reports the Long-term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest Core Breast Implant Trial To-Date

PR-M04-18-NI-011
Formulation

Differentiating Generic SODFs with Hard Capsule Formulations

PAO-Q1-18-CL-004
Acquistion

Avara Pharmaceutical Services Finalizes Acquisition of GSK Secondary Manufacturing and Packaging Facility in South Carolina

PR-M04-18-NI-015
Joint Venture

Medicrea Partners with Key Distributor to Form Joint Venture in Belgium

PR-M04-18-NI-010
Innovation

Aditlys Creates a Natural Tissue-Growing Implant to Treat Patients Suffering from Chronic Kidney Disease

PR-M04-18-NI-009
Innovation

Spinal Resources, Inc.® Announces First Implantation with Swedge™ Pedicle Screw System

PR-M04-18-NI-008
FDA

FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children

PR-M04-18-NI-007
Clinical Trials

Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy

PR-M04-18-NI-006
Clinical Trials

Wize Pharma Enrolls First Patient in Phase IV Study of LO2A for Symptomatic Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome

PR-M04-18-NI-005
Innovation

VICAM Introduces a New Method for BPA Detection

PR-M04-18-NI-004
FDA

Scholar Rock Granted Orphan Drug Designation by the FDA for SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

PR-M04-18-NI-003
Fast Track

Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients

PR-M04-18-NI-002
Clinical Trials

Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine

PR-M04-18-NI-001
Expanded Capacity

Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site

PR-M03-18-NI-105
Drug Development

Partnership to Develop Clostridial-Based Medicines Moves Forward

PR-M03-18-NI-104
Acquistion

FUJIFILM Expands into Bio-Medical Business with Acquisition

PR-M03-18-NI-103
Acquistion

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

PR-M03-18-NI-106
HIV

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

PR-M03-18-NI-111
Supply Chain

Intertek launches Inlight™ Advantage to accelerate the compliance onboarding process at every level of the supply chain 

PR-M03-18-NI-110
Oncology

Outcome Health And The Colorectal Cancer Alliance Announce Campaign To Support Patient Education

PR-M03-18-NI-109
CAR-T

bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States

PR-M03-18-NI-107
Cell and Gene Therapy

New Stem Cell Therapy Approved in Europe

PR-M03-18-NI-102
Clinical Data

Clinical Study Data for New MS Drug Looks Promising

PR-M03-18-NI-101
Probiotics

J&J Involved in Probiotics Development Program

PR-M03-18-NI-100
Operational Excellence

Transforming A CDMO Using an Operational Excellence Approach

PAO-M03-18-CL-003
Clinical Trials

BrainStorm Cell Therapeutics' Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients

PR-M03-18-NI-108
Awareness

Boehringer Ingelheim and Minor League Baseball Team Up to Raise Awareness of Rare Lung Disease – IPF

PR-M03-18-NI-106
Oncology

Biovica International AB: New Positive Results Support Early Treatment Evaluation of Breast Cancer Using DiviTum

PR-M03-18-NI-105
EMA

Ipsen Announces EMA Validation of Filing of a New Application for Additional Indication for Cabometyx®

PR-M03-18-NI-104
Conversion

Evotec AG plans conversion into European Company (SE)

PR-M03-18-NI-103
Acquistion

BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios 

PR-M03-18-NI-102
Clinical Data

New Study finds younger aged children with symptoms of ADHD have reduced brain size

PR-M03-18-NI-101
FDA

FDA approves Toujeo® Max SoloStar®

PR-M03-18-NI-101
Award

Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'

PR-M03-18-NI-099
Generic

Teva Announces the Launch of a Generic Version of Lialda® in the United States

PR-M03-18-NI-100
Clinical Trials

Clinical Trial Access to Expand Following Receipt of Additional Funding    

PAO-M03-18-NI-026
Acquisition

Citoxlab Acquires Solvo Biotechnology    

PAO-M03-18-NI-025
Ultrasound

Samsung Unveils New Innovative Ultrasound System at AIUM 2018

PR-M03-18-NI-097
Clinical Trials

Ipsen Receives Positive CHMP Opinion for Cabometyx®  (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma

PR-M03-18-NI-096
Clinical Data

Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS

PR-M03-18-NI-095
FDA

Novartis drug Tasigna® approved by FDA to treat children with rare form of leukemia

PR-M03-18-NI-094
Clinical Trials

Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX®  (varenicline) in Adolescent Smokers

PR-M03-18-NI-093
Blockbuster

Pace of Pharmaceutical Innovation Accelerates as Record Number of New Blockbuster Drugs Forecast to Hit the Market in 2018

PR-M03-18-NI-092
Discovery

New ALS Gene Discovered: KIF5A

PR-M03-18-NI-091
Partnership

Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies

PR-M03-18-NI-090
Clinical Data

Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal Phase 2 PACE Trial in Blood

PR-M03-18-NI-089
Clinical Trials

AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T)

PR-M03-18-NI-088
Drug Development

More Good News for Novo Nordisk’s Semaglutide and Weight Loss

PAO-M03-18-NI-024
Oncology

Adaptimmune’s GSK-Partnered T cells Trigger Responses in Solid Tumor Patients

PAO-M03-18-NI-023
Production

LANXESS Starts Production Line for Specialty Compounds in Germany

PAO-M03-18-NI-022
Influenza

Anti-Flu Drug Exploits Weakness in H3N2 Strain

PAO-M03-18-NI-021
Oncology

Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer

PAO-M03-18-NI-020
Acquistion

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification

PR-M03-18-NI-087
Clinical Trial Data

Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed in large prospective real-world analysis

PR-M03-18-NI-086
FDA

U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)

PR-M03-18-NI-085
Clinical Trials

Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System

PR-M03-18-NI-083
Immunotherapy

Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis

PR-M03-18-NI-082
Cannibis

Medical Marijuana Moves to the Big Time

PAO-M03-18-NI-019
Vaccine

Shingrix Vaccine Available at CVS

PAO-M03-18-NI-018
Expanded Capacity

Hovione Reports on Recent Capacity Expansion and Future Plans to Support Growth

PR-M03-18-NI-081
Appointment

Brammer Bio Expands Leadership Team for Commercial Readiness

PR-M03-18-NI-080
Capacity Expansion

Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion

PR-M03-18-NI-079
Appointment

AMPAC Fine Chemicals Announces New Addition To Their Executive Team

PR-M03-18-NI-078
×